000 | 01958 a2200541 4500 | ||
---|---|---|---|
005 | 20250518080811.0 | ||
264 | 0 | _c20210114 | |
008 | 202101s 0 0 eng d | ||
022 | _a2041-4889 | ||
024 | 7 |
_a10.1038/s41419-019-2212-y _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aThatikonda, Sowjanya | |
245 | 0 | 0 |
_aPiperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation. _h[electronic resource] |
260 |
_bCell death & disease _c01 2020 |
||
300 |
_a21 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aChemokines _xmetabolism |
650 | 0 | 4 |
_aDioxolanes _xpharmacology |
650 | 0 | 4 |
_aEpidermis _xpathology |
650 | 0 | 4 |
_aEpigenesis, Genetic _xdrug effects |
650 | 0 | 4 | _aHaCaT Cells |
650 | 0 | 4 |
_aHistone Deacetylase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aHistone Deacetylases _xmetabolism |
650 | 0 | 4 |
_aHistones _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImiquimod _xadverse effects |
650 | 0 | 4 |
_aInflammation _xdrug therapy |
650 | 0 | 4 |
_aKeratin-17 _xmetabolism |
650 | 0 | 4 |
_aKeratinocytes _xdrug effects |
650 | 0 | 4 | _aLipopolysaccharides |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aProtein Binding _xdrug effects |
650 | 0 | 4 |
_aPsoriasis _xchemically induced |
650 | 0 | 4 | _aRAW 264.7 Cells |
650 | 0 | 4 |
_aSTAT3 Transcription Factor _xmetabolism |
650 | 0 | 4 |
_aSkin _xpathology |
700 | 1 | _aPooladanda, Venkatesh | |
700 | 1 | _aSigalapalli, Dilep Kumar | |
700 | 1 | _aGodugu, Chandraiah | |
773 | 0 |
_tCell death & disease _gvol. 11 _gno. 1 _gp. 21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41419-019-2212-y _zAvailable from publisher's website |
999 |
_c30506308 _d30506308 |